Caregiver perceptions of psychotropic medication in residential facilities.

Aman et al. (1987) asked 227 caregivers in U.S. residential facilities about psychotropic medication. The survey wanted to know who influences drug choices and how staff feel about their training.

Caregivers said unit supervisors and doctors hold the most power. They also said they prefer behavior plans over pills.

Eighty-five percent of caregivers said their training on psychotropic drugs was poor. They wanted classes on behavioral alternatives.

Staff felt left out of prescribing talks. They wanted clear protocols and more say in decisions.

Li et al. (2018) asked the same questions to BCBAs and got the same answer: most behavior analysts also say their medication training is weak. The training gap spans both direct-care staff and credentialed clinicians.

Subramaniam et al. (2023) repeated the survey style with 89 family and professional caregivers of adults with IDD. They found caregivers now turn to the internet for drug facts, something G et al. never asked about. The information source has shifted, but the knowledge gap remains.

Agiovlasitis et al. (2025) moved from surveys to action. They gave community staff a short training package called SPECTROM. Antipsychotic dose reductions doubled at six months. The 1987 cry for better training finally has a working model.

If you work in a group home or day program, assume your team feels under-trained. Run a quick poll: ask five staff to rate their psychotropic knowledge 1-5. Then schedule a 30-minute behavior-skills refresher instead of a pill review. Use SPECTROM slides (free online) and track any dose changes three months later. You will turn a 37-year-old complaint into a live quality-improvement project.